The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation?

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

January 2, 2026: Happy New Year! We added two new Reverse 1999 codes which provide Clear Drops and more. What are the new Reverse 1999 codes? If you're making a start in Bluepoch's strategic RPG, ...

With the holidays are just around the corner, your savings might be taking a hit. Why not take a shot at one of the year's biggest Powerball jackpots? Saturday's prize has reached $1 billion and while ...

How many times have you gotten a call from an unknown number? This is a frequent occurrence for many people, especially with the rise of imposter spam calls contacting hundreds of cell phones at once.

A reverse mortgage allows seniors to access cash from the equity they've built up in their homes. Unlike home equity loans or HELOCs, there's usually no credit score requirement and you don't have to ...

Angelica Leicht is a seasoned personal finance writer and editor with nearly two decades of experience but just one goal: to help readers make the best decisions for their wallets. Her expertise spans ...

You must live in a house to have a reverse mortgage on it Matt Webber is an experienced personal finance writer, researcher, and editor. He has published widely on personal finance, marketing, and the ...